Australia markets open in 6 hours 56 minutes

ADMA Biologics, Inc. (ADMA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
6.70+0.03 (+0.52%)
As of 01:04PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 1.55B
Enterprise value 1.64B
Trailing P/E N/A
Forward P/E 22.99
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.79
Price/book (mrq)11.43
Enterprise value/revenue 6.34
Enterprise value/EBITDA 319.53

Trading information

Stock price history

Beta (5Y monthly) 0.43
52-week change 395.03%
S&P500 52-week change 323.57%
52-week high 36.76
52-week low 33.06
50-day moving average 36.12
200-day moving average 34.59

Share statistics

Avg vol (3-month) 32.53M
Avg vol (10-day) 32.24M
Shares outstanding 5231.77M
Implied shares outstanding 6231.77M
Float 8223.68M
% held by insiders 12.84%
% held by institutions 175.63%
Shares short (15 Apr 2024) 48.11M
Short ratio (15 Apr 2024) 43.32
Short % of float (15 Apr 2024) 43.60%
Short % of shares outstanding (15 Apr 2024) 43.50%
Shares short (prior month 15 Mar 2024) 47.99M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -10.94%
Operating margin (ttm)19.26%

Management effectiveness

Return on assets (ttm)4.51%
Return on equity (ttm)-19.67%

Income statement

Revenue (ttm)258.22M
Revenue per share (ttm)1.15
Quarterly revenue growth (yoy)47.90%
Gross profit (ttm)N/A
EBITDA 32.76M
Net income avi to common (ttm)-28.24M
Diluted EPS (ttm)-0.13
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)51.35M
Total cash per share (mrq)0.22
Total debt (mrq)141.42M
Total debt/equity (mrq)104.59%
Current ratio (mrq)5.16
Book value per share (mrq)0.60

Cash flow statement

Operating cash flow (ttm)8.8M
Levered free cash flow (ttm)378.12k